Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US) [NA]

View source ↗

Summary

The document notes that the VDyne Transcatheter Tricuspid Valve Replacement System (VISTA-US) is currently recruiting to evaluate safety and efficacy for tricus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VDyne Transcatheter Tricuspid Valve Replacement System

Snippet

Sponsor: VDyne, Inc. | Conditions: Tricuspid Regurgitation, Tricuspid Valve Disease | NA | Status: RECRUITING